Related Experiment Videos
Continuous immunotherapy for hymenoptera venom allergy using six month intervals
H W Baenkler1, S Meusser-Storm, G Eger
1Medical University Hospital III, Erlangen, Germany.
Allergologia Et Immunopathologia
|March 22, 2005
Summary
Continuous venom immunotherapy (VIT) at 6-month intervals provides long-term protection against bee and wasp venom allergies. This safe and effective approach reduces adverse events and offers an alternative to standard treatment protocols.
Area of Science:
- Allergy and Immunology
- Clinical Medicine
- Immunotherapy
Background:
- Hymenoptera venom allergy management relies on venom immunotherapy (VIT), which is effective but lacks clear treatment duration guidelines.
- Determining the optimal duration for VIT is challenging due to the absence of reliable tests for predicting severe reactions.
- This study investigated continuous VIT to ensure lifelong protection, exploring extended maintenance intervals to optimize patient management.
Purpose of the Study:
- To evaluate the long-term efficacy and safety of continuous venom immunotherapy (VIT) for Hymenoptera venom allergy.
- To assess the impact of increasing the maintenance interval to six months on adverse events and treatment effectiveness.
- To establish continuous VIT as a safe and effective alternative to current standard protocols.
Main Methods:
- A prospective study involving 176 patients with Hymenoptera venom allergy (wasp, bee, or both) over a mean of 7.14 years.
- Venom immunotherapy (VIT) was administered, with total and specific IgE levels monitored regularly.
- Patients were followed continuously, with maintenance intervals adjusted to six months to reduce workload and cost.
Main Results:
- Out of 162 reported re-stings, most resulted in local reactions; only one systemic reaction occurred, similar to pre-treatment severity.
- Total and specific IgE levels decreased during venom immunotherapy (VIT).
- Significant adverse effects were infrequent, not life-threatening, and managed according to established protocols; only one patient discontinued VIT due to adverse events.
Conclusions:
- Continuous venom immunotherapy (VIT) with six-month maintenance intervals provides lasting protection against bee and wasp venom allergies.
- This approach is a safe and effective alternative to existing standard treatment protocols.
- Long-term, continuous VIT ensures permanent protection and minimizes adverse events in allergic patients.